PTTG: an important target gene for ovarian cancer therapy

Siva Kumar Panguluri1, Casey Yeakel, Sham S Kakar

  • 1Department of Physiology and Biophysics, James Graham Brown Cancer Center, University of Louisville, Louisville, KY 40202, USA.

Journal of Ovarian Research
|November 19, 2008
PubMed

Insights

Pituitary tumor transforming gene (PTTG) drives tumor growth and metastasis. Inhibiting PTTG shows promise for suppressing cancer progression and developing new cancer therapies.

Area of Science:

  • Molecular biology
  • Genetics
  • Oncology

Background:

  • Pituitary tumor transforming gene (PTTG), also known as securin, plays a role in cell division and DNA repair.
  • High PTTG expression is observed in various tumors and proliferating cancer cells.
  • PTTG overexpression in vitro can lead to cellular transformation and tumor formation in vivo.

Purpose of the Study:

  • To review the structure, sub-cellular distribution, and cellular functions of PTTG.
  • To elucidate the role of PTTG in tumor progression, invasion, and metastasis.
  • To explore the potential of PTTG as a target for novel cancer therapies.

Main Methods:

  • Literature review of studies on PTTG.
  • Analysis of PTTG expression in cancer cell lines and tumors.
  • In vivo studies involving tumor xenografts.

Main Results:

  • PTTG is implicated in inhibiting sister chromatid separation and promoting angiogenesis and metastasis.
  • PTTG expression levels correlate with tumor progression, invasion, and metastasis.
  • Down-regulation of PTTG has been shown to suppress tumor growth in vitro and in vivo.

Conclusions:

  • PTTG is a key factor in tumorigenesis and cancer progression.
  • Targeting PTTG may offer a viable strategy for cancer treatment.
  • Further research into PTTG's mechanisms could lead to innovative therapeutic approaches.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...